Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pomplun

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 1998
A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancerR R Love, R Jacoby, M A Newton, et al.
Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithineP P Carbone, J A Douglas, P O Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suraminP R Hutson, K D Tutsch, R Rago, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 1998
A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancerR R Love, R Jacoby, M A Newton, et al.
Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithineP P Carbone, J A Douglas, P O Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suraminP R Hutson, K D Tutsch, R Rago, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Pageof 2